Masashi Mizuno

5.8k total citations
189 papers, 4.2k citations indexed

About

Masashi Mizuno is a scholar working on Nephrology, Immunology and Surgery. According to data from OpenAlex, Masashi Mizuno has authored 189 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Nephrology, 49 papers in Immunology and 35 papers in Surgery. Recurrent topics in Masashi Mizuno's work include Dialysis and Renal Disease Management (44 papers), Complement system in diseases (40 papers) and Renal Diseases and Glomerulopathies (19 papers). Masashi Mizuno is often cited by papers focused on Dialysis and Renal Disease Management (44 papers), Complement system in diseases (40 papers) and Renal Diseases and Glomerulopathies (19 papers). Masashi Mizuno collaborates with scholars based in Japan, United Kingdom and United States. Masashi Mizuno's co-authors include B. Paul Morgan, Seiichi Matsuo, Yasuhiko Ito, Claire L. Harris, Shoichi Maruyama, Yasuhíro Suzuki, Yukio Yuzawa, Christothea M. Constandinou, R. Christopher Benyon and Atsushi Harada and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Immunology.

In The Last Decade

Masashi Mizuno

180 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Mizuno Japan 35 1.1k 987 838 788 481 189 4.2k
Tim D. Hewitson Australia 43 516 0.5× 1.6k 1.6× 928 1.1× 1.4k 1.8× 490 1.0× 161 5.9k
Bernhard Banas Germany 41 1.6k 1.5× 1.4k 1.4× 1.1k 1.3× 1.4k 1.7× 311 0.6× 185 6.0k
Frank Eitner Germany 43 1.1k 1.1× 2.5k 2.5× 706 0.8× 1.7k 2.1× 460 1.0× 125 5.9k
Lene Heickendorff Denmark 51 416 0.4× 1.3k 1.3× 956 1.1× 1.1k 1.3× 726 1.5× 158 6.7k
Ching‐Yuang Lin Taiwan 34 721 0.7× 665 0.7× 690 0.8× 714 0.9× 172 0.4× 174 4.0k
Helmut Geiger Germany 38 465 0.4× 777 0.8× 1.4k 1.6× 1.1k 1.4× 1.3k 2.6× 185 5.9k
Theodore M. Danoff United States 26 956 0.9× 1.4k 1.4× 1.0k 1.2× 2.7k 3.5× 413 0.9× 47 6.7k
Shue‐Fen Luo Taiwan 37 906 0.9× 701 0.7× 476 0.6× 971 1.2× 135 0.3× 101 3.7k
Mario Schiffer Germany 41 1.0k 0.9× 3.3k 3.4× 812 1.0× 2.3k 2.9× 406 0.8× 246 7.0k
Jozélio Freire de Carvalho Brazil 35 1.0k 1.0× 265 0.3× 424 0.5× 570 0.7× 234 0.5× 275 4.3k

Countries citing papers authored by Masashi Mizuno

Since Specialization
Citations

This map shows the geographic impact of Masashi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Mizuno more than expected).

Fields of papers citing papers by Masashi Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Mizuno. The network helps show where Masashi Mizuno may publish in the future.

Co-authorship network of co-authors of Masashi Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Mizuno. A scholar is included among the top collaborators of Masashi Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Mizuno. Masashi Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatayama, Naoyuki, Mai Yamauchi, Hiroshi Kinashi, et al.. (2024). Role of endothelial hyaluronan in peritoneal membrane transport and disease conditions during peritoneal dialysis. Scientific Reports. 14(1). 7412–7412. 2 indexed citations
3.
Yasuda, Yoshinari, Aki Oshima, Yasuhíro Suzuki, et al.. (2023). Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients. BMC Nephrology. 24(1). 26–26. 4 indexed citations
4.
Mizuno, Masashi, et al.. (2023). ASSISTED PD:Problems and Countermeasures Based on Home-Visit Nursing Station Surveys. Nihon Toseki Igakkai Zasshi. 56(11). 401–409.
5.
Takahashi, Hiroshi, et al.. (2022). Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Patients at Dialysis Initiation. Nutrients. 14(11). 2317–2317. 17 indexed citations
6.
Sun, Ting, Yasuhíro Suzuki, Hiroshi Kinashi, et al.. (2021). Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis. Clinical and Experimental Nephrology. 25(9). 1035–1046. 9 indexed citations
7.
Nagano, Fumihiko, Tomohiro Mizuno, Masaki Imai, et al.. (2021). Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. FEBS Open Bio. 12(1). 192–202. 5 indexed citations
8.
Mizuno, Masashi, et al.. (2020). Impact on survival of urgent dialysis initiation in patients with end-stage renal disease: a case–control study. Clinical and Experimental Nephrology. 24(12). 1154–1161. 3 indexed citations
9.
Kinashi, Hiroshi, Naohiro Toda, Ting Sun, et al.. (2019). Connective tissue growth factor is correlated with peritoneal lymphangiogenesis. Scientific Reports. 9(1). 12175–12175. 11 indexed citations
10.
Chishima, Yuta, et al.. (2018). The Influence of Self-Compassion on Cognitive Appraisals and Coping with Stressful Events. Mindfulness. 9(6). 1907–1915. 55 indexed citations
11.
Ito, Yasuhiko, et al.. (2018). Current Status of Peritoneal Dialysis in Japan. Contributions to nephrology. 196. 123–128. 5 indexed citations
12.
Kato, Hideki, Yoshitaka Miyakawa, Yoshihiko Hidaka, et al.. (2018). Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance. Clinical and Experimental Nephrology. 23(1). 65–75. 16 indexed citations
13.
Mizuno, Masashi, Yasuhíro Suzuki, Fumiko Sakata, et al.. (2017). High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients. PLoS ONE. 12(1). e0169111–e0169111. 13 indexed citations
14.
Mizuno, Tomohiro, Masashi Mizuno, Mie Shimizu, et al.. (2017). Complement component 5 promotes lethal thrombosis. Scientific Reports. 7(1). 42714–42714. 28 indexed citations
15.
Nakata, Kei, Takayuki Miki, Masaya Tanno, et al.. (2016). Abstract 17519: Distinct Impacts of Sleep-disordered Breathing on Glycemic Variability in Patients With and Without Heart Failure. Circulation. 1 indexed citations
16.
Ito, Yasuhiko, Masashi Mizuno, Yasuhíro Suzuki, et al.. (2010). Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. Nephrology Dialysis Transplantation. 26(7). 2322–2332. 34 indexed citations
17.
Mizuno, Masashi, Yasuhiko Ito, Tomohiro Mizuno, et al.. (2009). Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model. The Journal of Immunology. 183(2). 1403–1412. 33 indexed citations
18.
Mizuno, Masashi, et al.. (2007). High Levels of Complement C3a Receptor in the Glomeruli in Lupus Nephritis. American Journal of Kidney Diseases. 49(5). 598–606. 24 indexed citations
19.
Harada, Atsushi, Masashi Mizuno, Marie Takemura, et al.. (2001). Hip Fracture Prevention Trial Using Hip Protectors in Japanese Nursing Homes. Osteoporosis International. 12(3). 215–221. 100 indexed citations
20.
Mizuno, Masashi, et al.. (1997). The effects of functional suppression of a membrane‐bound complement regulatory protein, CD59, in the synovial tissue in rats. Arthritis & Rheumatism. 40(3). 527–533. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026